India Stocks Fall on Geopolitical Fears; Analysts Split on 3 Key Names

BROKERAGE-REPORTS
Whalesbook Logo
AuthorRiya Kapoor|Published at:
India Stocks Fall on Geopolitical Fears; Analysts Split on 3 Key Names
Overview

On March 10, 2026, Indian markets face pressure from Middle East geopolitical tensions and rising oil prices. Mirae Asset's Somil Mehta issued specific trading calls: buy Aurobindo Pharma and Bharat Dynamics, sell Persistent Systems. This comes as defense stocks gain interest, pharma exports face disruption, and IT firms deal with high valuations.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Geopolitical Fears Drive Market Volatility

Indian equity markets are under pressure due to escalating geopolitical tensions in the Middle East, which have sent crude oil prices higher and led to substantial foreign investor outflows. This widespread investor caution has triggered broad selling across Indian stocks, with the Nifty 50 and Sensex seeing sharp declines in early March 2026. Amidst this volatility, specific stock recommendations, often based on technical indicators, require a closer look at their fundamentals and sector trends.

Analyst Issues Specific Stock Calls

Mirae Asset ShareKhan's Somil Mehta has provided technical views on three companies. For Aurobindo Pharma, a breakout above a trendline and trading above the 200-day Exponential Moving Average suggests positive momentum, with key levels at ₹1188 (support) and ₹1270 (resistance). Bharat Dynamics shows a technical breakout from consolidation, trading above short-term moving averages and supported by positive RSI divergence. Its levels are ₹1300 (support) and ₹1398 (resistance). Persistent Systems, however, exhibits technical weakness with lower tops and bottoms, facing resistance from its 10-day DEMA and negative momentum indicators. Its levels are ₹4587 (support) and ₹4873 (resistance). These technical signals come as market movements are largely driven by macro factors. On March 9, 2026, the Nifty 50 closed down 422 points at 24,028, and the Sensex fell 1,352 points to 77,566, reflecting investor caution and FII selling. The Indian rupee also depreciated.

Stock Analysis

Aurobindo Pharma Analysis

Mirae Asset's Somil Mehta recommends a buy for Aurobindo Pharma. The stock was trading around ₹1231.60 on March 6, 2026, with a market capitalization of approximately ₹71,532 crore. The pharmaceutical sector faces export disruptions due to geopolitical issues, potentially impacting March shipments by ₹2,500-₹5,000 crore due to doubled freight costs. However, domestic market growth remains strong, with ICRA projecting 8-10% for FY2026. Aurobindo's P/E ratio of about 20.36-20.53 is lower than its sector average of 32.42-61.83, suggesting fair valuation. While 12 analysts rate it 'Buy' with an average target of ₹1332-₹1345, MarketsMojo rates it 'Hold', citing modest historical growth and reliance on global markets as potential risks.

Bharat Dynamics Analysis

Bharat Dynamics receives a buy recommendation from Mirae Asset's Somil Mehta. Trading near ₹1356.70 on March 6, 2026, its market capitalization was around ₹49,065-₹49,732 crore as of March 8-9. The stock benefits from a strong domestic defense sector outlook, driven by government initiatives. However, its valuation is a key concern, with a P/E ratio of 85.76-92.64x significantly higher than the industry average of 54.5-67.35x. MarketsMojo rates it 'Strong Sell' due to expensive valuation and weak technicals. Analyst consensus is mixed, with 11 analysts offering 5 'Buy', 3 'Sell', and 3 'Hold' ratings, and an average target of approximately ₹1.56k.

Persistent Systems Analysis

Mirae Asset's Somil Mehta recommends selling Persistent Systems. Shares traded around ₹4775.20 on March 6, 2026, with a market capitalization of approximately ₹75,779 crore. The company operates in the IT services sector, which has faced selling pressure. Persistent boasts strong growth forecasts, with earnings expected to rise 19.9% annually. However, its P/E ratio of 43.58-56.23x is substantially higher than its sector average of 25.90x. Analyst ratings are mixed, with many 'Sell' or 'Strong Sell' recommendations leading to a recent downgrade to 'Hold'. While the average target suggests potential upside, the high valuation poses a risk.

Sector Outlook

Looking ahead, India's defense sector outlook remains positive, driven by government focus on domestic production and modernization. The pharmaceutical sector is projected for moderate growth, with domestic sales helping to offset export risks. The IT sector is expected to see earnings grow faster than the broader market, though performance will depend on valuations and market sentiment.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.